The present invention relates to amorphous and polymorphic forms of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate and their use for facilitating the delivery of active agents, such as insulin, to a target.

 
Web www.patentalert.com

< Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto

> Fibroblast growth factor-like polypeptides

~ 00458